ArticleJournal of diabetes and metabolic disorders2025

TMAO promotes metabolic dysfunction-associated fatty liver disease (MAFLD) development through long-non coding RNA- highly upregulated liver cancer (HULC).

Mohammad Moradzad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.